KOHESIO · Q3069310 · EE

Development of the Clinical Research Unit (Clinical Research Unit)

The National Centre for Transient Medicine and Clinical Research (RSKTK) is a national research infrastructure consisting of the University of Tartu, the Estonian University of Life Sciences and the University of Tartu Hospital, with the aim of enhancing health research in Estonia in order to contribute to the high level of development of medical research. In GNI, technologies and competences are available for biomedical, clinical and veterinary research. The CoR wants to be a partner for entrepreneurs and the state in carrying out research.

EU budget
€1.9M
Total project cost
€2.2M
Period
2017-01-01 → 2021-04-30
Thematic objective
TO01Research, technological development and innovation

About the Research, technological development and innovation objective

Thematic Objective 1 of the 2014–2020 Cohesion period funds research, technological development and innovation. It supports R&D infrastructure, technology transfer, business-academia partnerships and pilot lines that close the gap between scientific discovery and market application across EU regions.

Co-funding: the EU contributes €1.9M toward a total project cost of €2.2M — a co-funding rate of 85%, with the remainder covered by national, regional or private sources.

Kohesio is the European Commission's open-data platform for projects co-financed by the European Regional Development Fund, the European Social Fund Plus, the Cohesion Fund and the Just Transition Fund. It draws on lists of beneficiaries published by national managing authorities and harmonises them into a single EU-wide view.

Full project record on Kohesio — partners, deliverables, location map, related funding decisions.

Open on kohesio.ec.europa.eu →

Frequently asked questions

What is the EU budget for this project?
The EU contributes €1.9M toward a total project cost of €2.2M, a co-funding rate of 85%.
Which fund or thematic objective does it belong to?
This project falls under EU Cohesion Policy thematic objective TO01 — Research, technological development and innovation — financed through the European Structural and Investment Funds.
Which country is the project located in?
The project is located in EE.
What is the project period?
The project runs from 2017-01-01 to 2021-04-30.
Where can I find the full project record?
The complete project record — beneficiary, location and related funding decisions — is published on Kohesio, the European Commission's open-data platform, under reference Q3069310.